NiDCC

ipo — September 24, 2026, 5:15 AM · IndexBox

Rare Earths Americas Hits Heavy Rare Earth Enrichment at Homer Project in Brazil - News and Statistics

Rare Earths Americas (REA) has announced significant heavy rare earth enrichment at its Homer project in Brazil, with preliminary drilling results revealing extensive, shallow mineralization. The company, which focuses on heavy rare earth elements used in permanent magnets and defense, has completed over 6,500 meters of drilling and plans to finish the current drill program by year-end, aiming for an initial Mineral Resource Estimate in 2027. Despite these promising developments, REA's stock was down 1.3 percent in New York, and it holds a market capitalization of $219 million.

Explore more

ipo — September 24, 2026, 5:15 AM · Mining.com

High TREO concentrations boost Rare Earths Americas’ Homer project

Rare Earths Americas (REA) has reported promising initial drill results from its Homer project in Brazil, indicating widespread, near-surface mineralization with high concentrations of heavy rare earth oxides (HREO) and magnetic rare earth oxides. The company, which went public in May, is accelerating drilling with four rigs and plans to publish an initial Mineral Resource Estimate in 2027, highlighting the project's rapid advancement and potential for significant heavy rare earth enrichment.

Explore more

ipo — September 24, 2026, 3:44 AM · The National Law Review

Kaplan Fox Urges AEVEX Corp. (NYSE: AVEX) Investors to Contact the Firm Before the Deadline on October 20, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against AEVEX Corp. (NYSE: AVEX) on behalf of investors who purchased Class A Common Stock during or after its IPO between April 17, 2026, and June 4, 2026. The lawsuit alleges that the IPO offering documents contained material misrepresentations and omissions regarding a pre-arranged plan for a secondary public offering that would benefit Madison Dearborn Partners, LLC and the Underwriter Defendants by prematurely abrogating a 180-day "lock-up" commitment. Investors are urged to contact Kaplan Fox before the October 20, 2026 deadline to serve as lead plaintiff.

Explore more

ipo — September 24, 2026, 3:39 AM · GlobeNewswire

Robbins LLP Urges AVEX Stockholders to Contact the Firm for Information About the Class Action Against AEVEX Corp.

Robbins LLP is urging AEVEX Corp. (NYSE: AVEX) stockholders who suffered losses to contact the firm regarding a class action lawsuit. The lawsuit alleges that AEVEX concealed a pre-arranged plan for Madison, which owned most of AEVEX's common stock, to bypass a 180-day lock-up period and sell shares shortly after the IPO, earning Madison over $200 million. This led to a significant drop in AEVEX's stock price and market capitalization.

Explore more

ipo — September 24, 2026, 12:15 AM · Rare Earth Exchanges

Rare Earths Americas Homer-A Brazil Drill Results

Rare Earths Americas (NYSE American: REA) reported initial drill results from its Homer-A Project in Brazil, with a standout hole showing 22 meters at 2,298 ppm TREO+Sc. While the high dysprosium and terbium content is strategically significant, the project lacks a Mineral Resource Estimate and metallurgical data to confirm economic recoverability, indicating it is still an early-stage exploration project. REA's stock trades approximately 42% below its IPO price, reflecting the remaining exploration risks.

Explore more

ipo — September 23, 2026, 7:46 PM · Stock Titan

No takeover target is selected at Breeze Acquisition Corp. II (BREZ), which faces a deadline to complete a deal.

Breeze Acquisition Corp. II (BREZ) reported a net loss of $138,206 for the three months ended March 31, 2026, and disclosed substantial doubt about its ability to continue as a going concern due to not yet selecting a business-combination target and a material weakness in vendor-contract review controls. The company also received a Nasdaq notice for delinquent quarterly reports but has submitted a compliance plan. BREZ has until May 14, 2027, to complete a business combination.

Explore more

ipo — September 23, 2026, 7:44 PM · ACCESS Newswire

AVEX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that AEVEX Corp. Shareholders Have Opportunity to Lead Class Action Lawsuit!

Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against AEVEX Corp. (NYSE:AVEX) and some of its officers. The lawsuit claims that the IPO offering documents were misleading regarding a pre-arranged plan to waive lock-up restrictions for a secondary public offering shortly after the IPO, from which the company's private equity owner generated $207.9 million while AEVEX received no proceeds. Investors who purchased AEVEX Class A common stock between April 17, 2026, and June 4, 2026, are encouraged to join the lawsuit and have until October 20, 2026, to request to be appointed lead plaintiff.

Explore more

ipo — September 23, 2026, 6:43 PM · Insider Monkey

Nvidia Backed This AI Drug Startup. AbbVie Just Became a Partner Before Its IPO

Iambic Therapeutics, an AI drug discovery startup backed by Nvidia and Qatar Investment Authority, has filed for a U.S. IPO and simultaneously announced a multi-year research collaboration with AbbVie. The partnership involves AbbVie making an upfront payment of $40 million and potential milestone payments of up to $670 million, allowing it to leverage Iambic's AI platform for drug design in immunology, neuroscience, and oncology. This development highlights how AI models could accelerate pharmaceutical R&D, benefiting both the drug company seeking new molecules and the chip supplier expanding the ecosystem for its hardware and software.

Explore more

ipo — September 23, 2026, 2:42 PM · Yahoo Finance

Nvidia Backed This AI Drug Startup. AbbVie Just Became a Partner Before Its IPO

Iambic Therapeutics, an AI drug discovery startup backed by Nvidia and the Qatar Investment Authority, has filed for a U.S. IPO and simultaneously announced a multi-year research collaboration with AbbVie Inc. AbbVie will use Iambic's AI platform for small-molecule programs across immunology, neuroscience, and oncology, with an upfront payment and potential milestones. Nvidia's investment aims to expand the ecosystem for its hardware and software, benefiting from increased demand for accelerated computing in drug design.

Explore more

ipo — September 23, 2026, 1:07 PM · PR Newswire

AVEX UPCOMING DEADLINE: Levi & Korsinsky Alerts AEVEX Corp. Stockholders of Securities Class Action - Contact the Firm

Levi & Korsinsky, LLP has filed a securities class action against AEVEX Corp. (NYSE: AVEX) on behalf of investors who purchased shares between April 17, 2026, and June 4, 2026. The lawsuit alleges that AEVEX's IPO registration statement contained misleading information regarding a 180-day lock-up period for its principal stockholder, which was allegedly waived for a secondary offering, leading to a significant loss in market value. Investors who suffered losses have until October 20, 2026, to seek appointment as lead plaintiff.

Explore more

Insights and Intelligence